Generalizability Network Research Study
Columbia University is looking for collaborators to run their Generalizability, Applicability, and Replicability of RCTs Study. To learn more about the study, check out @aaveritt's presentation from the July 10th community call: https://drive.google.com/file/d/1acWhR5FCsTMWL7hxmYCgVlUt6r1bBFm1/view?usp=sharing
The study protocol is posted here: OHDSI/StudyProtocolSandbox/Generalizability
To participate in the study, please contact let @aaveritt know by replying to her forum post:
OHDSI MEETINGS THIS WEEK
OHDSI Community Call - Tuesday at 12pm ET
US TOLL: +1-415-655-0001
Meeting Number: 199 982 907
GIS working group meeting - Next Monday (September 17th) at 10am ET
Meeting Number: 735 317 239
2018 Collaborator Showcase - NOTIFICATIONS SENT TO AUTHORS
All authors who submitted abstracts for this year's collaborator showcase have been notifified about the status of their submission. If you did not recieve a notification, please email email@example.com. More information about the collaborator showcase, including presentation logistics and poster templates,is available here: https://www.ohdsi.org/collaborator-showcase/
Insanity doesn’t run in my family, it gallops.
- Cary Grant
Choosing the Target Difference (“effect size”) for a Randomised Controlled Trial - DELTA2 Guidance
Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin
DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
Methodological variations in lagged regression for detecting physiologic drug effects in EHR data.
Contributions from the 2017 Literature on Clinical Decision Support.